Akumentis Healthcare Posts ₹66 Cr Profit in FY25; Revenue Grows 9%

Akumentis Healthcare has reported a profit of ₹66 crore and a 9% revenue growth for the financial year 2025. The company's performance reflects its strategic initiatives in expanding product lines and improving operational efficiencies. Akumentis continues to focus on delivering quality healthcare solutions and strengthening its market presence. The growth trajectory positions the company well for future opportunities in the pharmaceutical industry. Akumentis aims to leverage its financial performance to invest in research and development, ensuring sustained growth and innovation in the coming years.